Literature DB >> 29895984

Correction: ACG Clinical Guideline: Treatment of Helicobacter pylori Infection.

William D Chey, Grigorios I Leontiadis, Colin W Howden, Steven F Moss.   

Abstract

Since the publication of this manuscript it was realised that reference 14 was provided incorrectly. The correct reference is provided here.

Entities:  

Year:  2018        PMID： 29895984     DOI： 10.1038/s41395-018-0132-6

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN： 0002-9270            Impact factor:   10.864


  3 in total

1.  Efficacy of tailored second-line therapy of Helicobacter pylori eradication in patients with clarithromycin-based treatment failure: a multicenter prospective study.

Authors:  Siya Kong; Keting Huang; Jun Wang; Guoxin Zhang; Feng Ye; Xiaoyong Wang; Ningmin Yang; Yu Dong; Ya Zhuang; Yini Dang
Journal:  Gut Pathog       Date:  2020-08-29       Impact factor: 4.181

2.  Comparison of the Dual Therapy of Ilaprazole-Amoxicillin and the Bismuth Quadruple Therapy of Ilaprazole-Amoxicillin-Furazolidone-Bismuth Glycyrrhizinate for Eradication of Helicobacter pylori.

Authors:  Min Niu; Yan Zhou; Yunqian Xie; Xue Li; Yonggang Tian; Li Yao; Ximei Li; Hengjun Gao; Feihu Bai
Journal:  Front Pharmacol       Date:  2022-04-27       Impact factor: 5.810

3.  Evaluation of the Effectiveness of Helicobacter pylori Eradication Regimens in Lithuania during the Years 2013-2020: Data from the European Registry on Helicobacter pylori Management (Hp-EuReg).

Authors:  Paulius Jonaitis; Juozas Kupcinskas; Olga P Nyssen; Ignasi Puig; Javier P Gisbert; Laimas Jonaitis
Journal:  Medicina (Kaunas)       Date:  2021-06-23       Impact factor: 2.430
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.